BACKGROUND: The mechanisms underlying the progression of prostate cancer to androgen-resistant cancer are still not fully understood. Here, we studied the genetic events associated with this transformation. METHODS: The androgen sensitive prostate cancer cells line LNCaP-FGC and its androgen resistant subline LNCaP-r were investigated using SKY, CGH, and cDNA microarray. RESULTS: Karyotypically, several additional chromosomal aberrations were seen in LNCaP-r as compared to the parental line. CGH also revealed unique net chromosomal alterations in LNCaP-r compared to LNCaP-FGC, including gain of 2p13-23, 2q21-32, and 13q and loss of 6p22-pter. cDNA microarray analysis identified several genes involved in DNA methylation, such as DNMT2, DNMT3a, and methyl-CpG binding domain protein 2 and 4 that were higher expressed in LNCaP-r. Interestingly, androgen responsiveness of LNCaP-r was restored after treated with DNA methyltransferase inhibitor. CONCLUSIONS: Our findings may serve as a basis for molecular dissection of the mechanisms involved in development of androgen resistant prostate cancer. Copyright 2005 Wiley-Liss, Inc.
BACKGROUND: The mechanisms underlying the progression of prostate cancer to androgen-resistant cancer are still not fully understood. Here, we studied the genetic events associated with this transformation. METHODS: The androgen sensitive prostate cancer cells line LNCaP-FGC and its androgen resistant subline LNCaP-r were investigated using SKY, CGH, and cDNA microarray. RESULTS: Karyotypically, several additional chromosomal aberrations were seen in LNCaP-r as compared to the parental line. CGH also revealed unique net chromosomal alterations in LNCaP-r compared to LNCaP-FGC, including gain of 2p13-23, 2q21-32, and 13q and loss of 6p22-pter. cDNA microarray analysis identified several genes involved in DNA methylation, such as DNMT2, DNMT3a, and methyl-CpG binding domain protein 2 and 4 that were higher expressed in LNCaP-r. Interestingly, androgen responsiveness of LNCaP-r was restored after treated with DNA methyltransferase inhibitor. CONCLUSIONS: Our findings may serve as a basis for molecular dissection of the mechanisms involved in development of androgen resistant prostate cancer. Copyright 2005 Wiley-Liss, Inc.
Authors: Juna Lee; Se Jin Jang; Nicole Benoit; Mohammad O Hoque; Joseph A Califano; Barry Trink; David Sidransky; Li Mao; Chulso Moon Journal: Genomics Date: 2010-04-09 Impact factor: 5.736
Authors: Yan P Yu; Chi Song; George Tseng; Bao Guo Ren; William LaFramboise; George Michalopoulos; Joel Nelson; Jian-Hua Luo Journal: Am J Pathol Date: 2012-05-07 Impact factor: 4.307
Authors: Tao Wang; Lucia R Languino; Jane Lian; Gary Stein; Michael Blute; Thomas J Fitzgerald Journal: Front Oncol Date: 2011-07-13 Impact factor: 6.244
Authors: Yan P Yu; Silvia Liu; Zhiguang Huo; Amantha Martin; Joel B Nelson; George C Tseng; Jian-Hua Luo Journal: PLoS One Date: 2015-08-21 Impact factor: 3.240